News

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with…
Read More...

Tyligand Bioscience, Ltd. and Context Therapeutics LLC announced the signing of collaboration agreements for the manufacturing, registration and future commercialization of onapristone…
Read More...

AbCellera and Eli Lilly and Company announced they have entered into an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease caused by the…
Read More...

Vir Biotechnology, Inc. announced that it has signed a letter of intent with Biogen Inc. (Nasdaq: BIIB) for the development and clinical manufacturing of human monoclonal antibodies for…
Read More...

Emergent BioSolutions Inc. announced that it has initiated development of two product candidates for the treatment and prevention of coronavirus disease (COVID-19). These product…
Read More...

NICE has today (12 March 2020) published final draft guidance which recommends fremanezumab (also called Ajovy and made by Teva Pharmaceuticals) for preventing chronic migraine. The…
Read More...

Harbour BioMed (HBM) announced successful completion of its Series B+ round financing of $75 million to accelerate the advancement of its clinical-stage compounds and growing portfolio…
Read More...

Kuur Therapeutics announced the launch of its new business in partnership with Baylor College of Medicine and Baylor’s Center for Cell and Gene Therapy. Houston-based Kuur Therapeutics…
Read More...

Bristol Myers Squibb Company announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved by the U.S. Food and Drug…
Read More...

WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy, and Cognate BioServices, Inc., a leading contract development…
Read More...

Chime Biologics announced operations as an independent and stand-alone Biologics CDMO company. With the separation from JHL Biotech complete, Chime Biologics is now focused on…
Read More...

InMed Pharmaceuticals Inc. reported completed enrollment in its first Phase 1 clinical trial with INM-755 in healthy subjects (Study 755-101-HV). INM-755 is a CBN cream intended as a…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

Novavax, Inc. a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations…
Read More...

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic The Bill & Melinda Gates…
Read More...

Today, AnaBios announced a Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) to study adult human primary cardiomyocytes as a reference for…
Read More...

Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology…
Read More...

Nanoform, an innovative nanoparticle medicine enabling company, and Orion Corporation, a Finnish pharmaceutical company, announced a collaboration to apply Nanoform's award-winning CESS…
Read More...

ViiV Healthcare and the University of North Carolina at Chapel Hill announced a five-year, $20 million renewal of a unique, public-private research partnership solely focused on…
Read More...

AbbVie confirmed the company's activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia…
Read More...